Director Declaration

Dechra Pharmaceuticals PLC
29 November 2023
 

29 November 2023

 

Dechra® Pharmaceuticals PLC

(Dechra or the Company)

LEI: 213800J4UVB5OWG8VX82

 

DIRECTOR DECLARATION

 

 

In accordance with Listing Rule 9.6.14(2) Dechra announces that Alison Platt, Non-Executive Chair of Dechra, has been appointed as a Chair of the Board and Non-Executive Director of Hargreaves Lansdown plc in early 2024.

 

For further information, please contact:

Dechra Pharmaceuticals PLC

Telephone number:  +44 (0) 1606 814730

Email: corporate.enquiries@dechra.com

 

 

About Dechra

Dechra is a global veterinary pharmaceuticals and related products business.  Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information, please visit: www.dechra.com.

 

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Dechra Pharmaceuticals (DPH)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today